|
 |
|
|||||||
|
|||||||||
Diabetes 52:1023-1030, 2003
© 2003 by the American Diabetes Association, Inc.
Nephrin Expression Is Reduced in Human Diabetic Nephropathy
Evidence for a Distinct Role for Glycated Albumin and Angiotensin II
1 Department of Internal Medicine, University of Turin, Center for Experimental Research and Medical Sciences (CERMS), Turin, Italy
2 Department of Internal Medicine, University of Genoa, Genoa, Italy
3 Department of Biochemistry, University of Oulu, Oulu, Finland
We studied the distribution of nephrin in renal biopsies from 17 patients with diabetes and nephrotic syndrome (7 type 1 and 10 type 2 diabetes), 6 patients with diabetes and microalbuminuria (1 type 1 and 5 type 2 diabetes), and 10 normal subjects. Nephrin expression was semiquantitatively evaluated by measuring immunofluorescence intensity by digital image analysis. We found an extensive reduction of nephrin staining in both type 1 (67 ± 9%; P < 0.001) and type 2 (65 ± 10%; P < 0.001) diabetic patients with diabetes and nephrotic syndrome when compared with control subjects. The pattern of staining shifted from punctate/linear distribution to granular. In patients with microalbuminuria, the staining pattern of nephrin also showed granular distribution and reduction intensity of 69% in the patient with type 1 diabetes and of 62 ± 4% (P < 0.001) in the patients with type 2 diabetes. In vitro studies on human cultured podocytes demonstrated that glycated albumin and angiotensin II reduced nephrin expression. Glycated albumin inhibited nephrin synthesis through the engagement of receptor for advanced glycation end products, whereas angiotensin II acted on cytoskeleton redistribution, inducing the shedding of nephrin. This study indicates that the alteration in nephrin expression is an early event in proteinuric patients with diabetes and suggests that glycated albumin and angiotensin II contribute to nephrin downregulation.
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  V. Thallas-Bonke, S. R. Thorpe, M. T. Coughlan, K. Fukami, F. Y.T. Yap, K. C. Sourris, S. A. Penfold, L. A. Bach, M. E. Cooper, and J. M. Forbes Inhibition of NADPH Oxidase Prevents Advanced Glycation End Product-Mediated Damage in Diabetic Nephropathy Through a Protein Kinase C-{alpha}-Dependent Pathway Diabetes, February 1, 2008; 57(2): 460 - 469. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Ideura, K. Hiromura, N. Hiramatsu, T. Shigehara, S. Takeuchi, M. Tomioka, T. Sakairi, S. Yamashita, A. Maeshima, Y. Kaneko, et al. Angiotensin II provokes podocyte injury in murine model of HIV-associated nephropathy Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1214 - F1221. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-J. Kim, J. J. Li, D.-S. Jung, S.-J. Kwak, D.-R. Ryu, T.-H. Yoo, S. H. Han, H. Y. Choi, H. J. Kim, D. S. Han, et al. Differential Expression of Nephrin According to Glomerular Size in Early Diabetic Kidney Disease J. Am. Soc. Nephrol., August 1, 2007; 18(8): 2303 - 2310. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Takano, K. Yamauchi, N. Hiramatsu, A. Kasai, K. Hayakawa, M. Yokouchi, J. Yao, and M. Kitamura Recovery and maintenance of nephrin expression in cultured podocytes and identification of HGF as a repressor of nephrin Am J Physiol Renal Physiol, May 1, 2007; 292(5): F1573 - F1582. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J.M. Coward, G. I. Welsh, A. Koziell, S. Hussain, R. Lennon, L. Ni, J. M. Tavare, P. W. Mathieson, and M. A. Saleem Nephrin Is Critical for the Action of Insulin on Human Glomerular Podocytes Diabetes, April 1, 2007; 56(4): 1127 - 1135. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Hiramatsu, K. Hiromura, T. Shigehara, T. Kuroiwa, H. Ideura, N. Sakurai, S. Takeuchi, M. Tomioka, H. Ikeuchi, Y. Kaneko, et al. Angiotensin II Type 1 Receptor Blockade Inhibits the Development and Progression of HIV-Associated Nephropathy in a Mouse Model J. Am. Soc. Nephrol., February 1, 2007; 18(2): 515 - 527. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Cohen, G. T. Lautenslager, E. Hud, E. Shea, A. Wang, S. Chen, and C. W. Shearman Inhibiting albumin glycation attenuates dysregulation of VEGFR-1 and collagen IV subchain production and the development of renal insufficiency Am J Physiol Renal Physiol, February 1, 2007; 292(2): F789 - F795. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Benck, S. Haeckel, J. H. Clorius, and F. J. van der Woude Proteinuria-Lowering Effect of Heparin Therapy in Diabetic Nephropathy without Affecting the Renin-Angiotensin-Aldosterone System Clin. J. Am. Soc. Nephrol., January 1, 2007; 2(1): 58 - 67. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Uribarri and K. R. Tuttle Advanced Glycation End Products and Nephrotoxicity of High-Protein Diets Clin. J. Am. Soc. Nephrol., November 1, 2006; 1(6): 1293 - 1299. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Sung, F. N. Ziyadeh, A. Wang, P. E. Pyagay, Y. S. Kanwar, and S. Chen Blockade of Vascular Endothelial Growth Factor Signaling Ameliorates Diabetic Albuminuria in Mice J. Am. Soc. Nephrol., November 1, 2006; 17(11): 3093 - 3104. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Giunti, D. Barit, and M. E. Cooper Mechanisms of Diabetic Nephropathy: Role of Hypertension Hypertension, October 1, 2006; 48(4): 519 - 526. [Full Text] [PDF]
|
|
|
|
 |
|
 I. Quack, L. C. Rump, P. Gerke, I. Walther, T. Vinke, O. Vonend, T. Grunwald, and L. Sellin beta-Arrestin2 mediates nephrin endocytosis and impairs slit diaphragm integrity PNAS, September 19, 2006; 103(38): 14110 - 14115. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. R. Lester, C. M. Crill, and E. B. Hak Should adding albumin to parenteral nutrient solutions be considered an unsafe practice? Am. J. Health Syst. Pharm., September 1, 2006; 63(17): 1656 - 1661. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Ichinose, Y. Maeshima, Y. Yamamoto, M. Kinomura, K. Hirokoshi, H. Kitayama, Y. Takazawa, H. Sugiyama, Y. Yamasaki, N. Agata, et al. 2-(8-Hydroxy-6-Methoxy-1-Oxo-1H-2-Benzopyran-3-yl) Propionic Acid, an Inhibitor of Angiogenesis, Ameliorates Renal Alterations in Obese Type 2 Diabetic Mice. Diabetes, May 1, 2006; 55(5): 1232 - 1242. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Macconi, M. Abbate, M. Morigi, S. Angioletti, M. Mister, S. Buelli, M. Bonomelli, P. Mundel, K. Endlich, A. Remuzzi, et al. Permselective Dysfunction of Podocyte-Podocyte Contact upon Angiotensin II Unravels the Molecular Target for Renoprotective Intervention Am. J. Pathol., April 1, 2006; 168(4): 1073 - 1085. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Liebau, D. Lang, J. Bohm, N. Endlich, M. J. Bek, I. Witherden, P. W. Mathieson, M. A. Saleem, H. Pavenstadt, and K.-G. Fischer Functional expression of the renin-angiotensin system in human podocytes Am J Physiol Renal Physiol, March 1, 2006; 290(3): F710 - F719. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Gu, S. Hagiwara, Q. Fan, M. Tanimoto, M. Kobata, M. Yamashita, T. Nishitani, T. Gohda, Z. Ni, J. Qian, et al. Role of receptor for advanced glycation end-products and signalling events in advanced glycation end-product-induced monocyte chemoattractant protein-1 expression in differentiated mouse podocytes Nephrol. Dial. Transplant., February 1, 2006; 21(2): 299 - 313. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Londono and M. Bendayan Glomerular handling of native albumin in the presence of circulating modified albumins by the normal rat kidney Am J Physiol Renal Physiol, December 1, 2005; 289(6): F1201 - F1209. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. G. Ewens, R. A. George, K. Sharma, F. N. Ziyadeh, and R. S. Spielman Assessment of 115 Candidate Genes for Diabetic Nephropathy by Transmission/Disequilibrium Test Diabetes, November 1, 2005; 54(11): 3305 - 3318. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Ichinose, Y. Maeshima, Y. Yamamoto, H. Kitayama, Y. Takazawa, K. Hirokoshi, H. Sugiyama, Y. Yamasaki, K. Eguchi, and H. Makino Antiangiogenic Endostatin Peptide Ameliorates Renal Alterations in the Early Stage of a Type 1 Diabetic Nephropathy Model Diabetes, October 1, 2005; 54(10): 2891 - 2903. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Wolf, S. Chen, and F. N. Ziyadeh From the Periphery of the Glomerular Capillary Wall Toward the Center of Disease: Podocyte Injury Comes of Age in Diabetic Nephropathy Diabetes, June 1, 2005; 54(6): 1626 - 1634. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Nosadini, M. Velussi, E. Brocco, C. Abaterusso, F. Piarulli, G. Morgia, A. Satta, R. Faedda, A. Abhyankar, H. Luthman, et al. Altered Transcapillary Escape of Albumin and Microalbuminuria Reflects Two Different Pathogenetic Mechanisms Diabetes, January 1, 2005; 54(1): 228 - 233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Yamamoto, Y. Maeshima, H. Kitayama, S. Kitamura, Y. Takazawa, H. Sugiyama, Y. Yamasaki, and H. Makino Tumstatin Peptide, an Inhibitor of Angiogenesis, Prevents Glomerular Hypertrophy in the Early Stage of Diabetic Nephropathy Diabetes, July 1, 2004; 53(7): 1831 - 1840. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Toyoda, D. Suzuki, T. Umezono, G. Uehara, M. Maruyama, M. Honma, T. Sakai, and H. Sakai Expression of human nephrin mRNA in diabetic nephropathy Nephrol. Dial. Transplant., February 1, 2004; 19(2): 380 - 385. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |